Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and deliver significant savings. Coherus’ strategy is to build a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business.